KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Revenue: 2016-2024

Historic Revenue for Aurinia Pharmaceuticals (AUPH) over the last 9 years, with Dec 2024 value amounting to $235.1 million.

  • Aurinia Pharmaceuticals' Revenue rose 8.41% to $73.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $265.8 million, marking a year-over-year increase of 20.62%. This contributed to the annual value of $235.1 million for FY2024, which is 33.97% up from last year.
  • As of FY2024, Aurinia Pharmaceuticals' Revenue stood at $235.1 million, which was up 33.97% from $175.5 million recorded in FY2023.
  • Aurinia Pharmaceuticals' 5-year Revenue high stood at $235.1 million for FY2024, and its period low was $45.6 million during FY2021.
  • For the 3-year period, Aurinia Pharmaceuticals' Revenue averaged around $181.6 million, with its median value being $175.5 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first spiked by 15,660.38% in 2020, then dropped by 9.00% in 2021.
  • Yearly analysis of 5 years shows Aurinia Pharmaceuticals' Revenue stood at $50.1 million in 2020, then declined by 9.00% to $45.6 million in 2021, then spiked by 193.89% to $134.0 million in 2022, then spiked by 30.95% to $175.5 million in 2023, then surged by 33.97% to $235.1 million in 2024.